Goldman Sachs’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Goldman Sachs’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-81,373	Closed	-$6.1M	–	7667
2015 Q3	$6.1M	Buy	81,373 +2,505	+3%	+$187K	﹤0.01%	2705
2015 Q2	$5.94M	Buy	78,868 +49,173	+166%	+$2.63M	﹤0.01%	2824
2015 Q1	$1.49M	Buy	29,695 +14,161	+91%	+$594K	﹤0.01%	4074
2014 Q4	$539K	Sell	15,534 -17,752	-53%	-$619K	﹤0.01%	5212
2014 Q3	$1.09M	Buy	33,286 +20,428	+159%	+$719K	﹤0.01%	4517
2014 Q2	$493K	Buy	12,858 +4,031	+46%	+$141K	﹤0.01%	5335
2014 Q1	$351K	Buy	+8,827	New	+$395K	﹤0.01%	5601

Goldman Sachs's KYTH Position: Q4 2015 in Review

Goldman Sachs sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 81,373 shares — an estimated $6.1M sold.

Goldman Sachs first reported a position in KYTH in Q1 2014 and held it in 7 quarters. The position peaked at $6.1M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

Goldman Sachs reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
Goldman Sachs sold 81,373 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $6.1M.
Goldman Sachs first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q1 2014 and held it in 7 quarters.
Goldman Sachs's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $6.1M in Q3 2015.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Goldman Sachs's 13F filing for Q4 2015, filed 16 Feb 2016.